.svg){kind=small}
Jul-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of New York, Chime & Chill has shown notable consistency in the Tincture & Sublingual category, maintaining a steady rank of 10th from April through June 2025, before experiencing a slight drop to 11th in July. This indicates a stable presence in the market, although the dip in July suggests potential challenges or increased competition. In contrast, their performance in the Topical category was strong, holding the 3rd position in both April and May. However, it is worth noting that they were not ranked in the Topical category for June and July, which could imply a significant drop in sales or a strategic shift away from this category.
Analyzing the sales figures, Chime & Chill's Tincture & Sublingual sales peaked in May 2025, with a notable increase from April, but saw a decline in June and July. This trend could suggest seasonal variations or changes in consumer preferences. Meanwhile, the absence of ranking data for the Topical category after May highlights a potential area of concern or a strategic realignment. The lack of presence in the top 30 for June and July might indicate a need for Chime & Chill to reassess their approach in this segment. These movements across categories and rankings offer insights into the brand's market dynamics and potential areas for growth and improvement.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Chime & Chill has experienced some notable shifts in its market position over recent months. Despite maintaining a consistent rank of 10th place from April to June 2025, Chime & Chill saw a slight decline to 11th place in July 2025. This drop in rank coincides with a decrease in sales from June to July, suggesting a potential challenge in maintaining market share. In contrast, Jumbodose held a stronger position, consistently ranking within the top 10, although it also experienced a downward trend, moving from 7th to 9th place over the same period. Meanwhile, Harney Brothers Cannabis entered the top 20 in July, debuting at 10th place, which may have contributed to Chime & Chill's drop in rank. These dynamics highlight the competitive pressures Chime & Chill faces in maintaining its position and underscore the importance of strategic adjustments to regain and enhance its market standing.
Notable Products
In July 2025, the top-performing product from Chime & Chill was the K.O. - CBD Double Dose Tincture (4500mg CBD, 30ml) in the Tincture & Sublingual category, maintaining its first-place rank for the third consecutive month with sales of 175 units. The CBD/CBN 2:1 PM Lotion (300mg CBD, 150mg CBN) in the Topical category rose to second place, improving from its fourth-place position in June. The CBD/CBG 2:1 AM Body Cream (300mg CBD, 150mg CBG), also in the Topical category, held steady in third place, consistent with its ranking in June. In the Edible category, the CBD/CBC/CBG 4:5:5 Light & Sweet - White Chocolate & Espresso Pick-Me-Up Melts 20-Pack (240mg CBD, 300mg CBC, 300mg CBG) secured the fourth spot, having dropped from third place in May. The CBD/CBG 2:1 AM Oral Solution (200mg CBD, 100mg CBG) entered the rankings in fifth place, marking its return to the list since May.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
